TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancer, today announced the ...

TransCode Therapeutics ( ($RNAZ) ) just unveiled an update. On January 6, 2026, TransCode Therapeutics announced the publication in the Journal of ...

So long as you choose the right client for the job, your NAS can simply send the file over to the TV, tablet, or streaming ...

To support VIP at true sports scale, we needed a reliable and flexible live-video workflow foundation—in 2025 alone, we ...

Investing.com -- TransCode Therapeutics (NASDAQ:RNAZ) stock surged 18% on Tuesday after the company published preclinical data showing its lead candidate TTX-MC138 demonstrated therapeutic potential ...

Against a backdrop of insatiable demand for compute, Web3 principles and technologies offer enterprises transparent, flexible ...

Publishes Preclinical Data Supporting TTX-MC138 For Glioblastoma. TransCode Therapeutics (NASDAQ: RNAZ) announced the publication of peer-reviewed preclinical research supporting the use of its lead ...

A new report on the consumer health industry has found the COVID-19 aftermath has largely worn off, and forward progress is emerging again. This is headlined by a growing focus on healthy aging ? a ...

Super Micro Computer, Inc. (SMCI), a Total IT Solution Provider for AI/ML, HPC, Cloud, Storage, and 5G/Edge, will showcase ...

Manufacturer will showcase its IP media management system, unified control platform, and Cradle Series RF02 modular expansion ...

For over 45 years, arts and media organization BRIC Brooklyn has shaped the borough’s cultural landscape across visual arts, ...

UNIONDALE, NY / ACCESS Newswire / January 6, 2026 / Marquis Who's Who honors Jason A. Marks, MBA-HCM, for his expertise in ...